MerTK expression was also observed in immune infiltrate in other tumor types such as in pancreas duct adenocarcinoma, in head and neck, skin and cervix squamous cell carcinoma, in ovary, uterus, and prostate adenocarcinoma as well as in kidney clear cell and granular cell tumors (Supplementary Table 2). This evidence concerns the gene MERTK and cervical squamous cell carcinoma.